These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37356017)

  • 1. [Diabetes mellitus and the intestinal microbiome].
    Tomasics G; Schandl L; Polyák A; Winkler G
    Orv Hetil; 2023 Jun; 164(25):981-987. PubMed ID: 37356017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between intestinal hyperpermeability and obesity].
    Ságodi L; Sólyom E; Ságodi L; Almási A
    Orv Hetil; 2022 Aug; 163(32):1261-1267. PubMed ID: 35933621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the microbiome in the management of children with type 2 diabetes mellitus.
    Brar PC; Kohn B
    Curr Opin Pediatr; 2019 Aug; 31(4):524-530. PubMed ID: 31299021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the gut and oral microbiome with obesity.
    Gasmi Benahmed A; Gasmi A; Doşa A; Chirumbolo S; Mujawdiya PK; Aaseth J; Dadar M; Bjørklund G
    Anaerobe; 2021 Aug; 70():102248. PubMed ID: 32805390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
    Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
    Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance and effects of prenatal and postnatal microbiome in the period of early individual development and options for interventional treatment].
    Fülöp V; Demeter J; Cseh Á
    Orv Hetil; 2021 May; 162(19):731-740. PubMed ID: 33965906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome Changes in Gestational Diabetes.
    Ionescu RF; Enache RM; Cretoiu SM; Gaspar BS
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.
    Needell JC; Zipris D
    Curr Diab Rep; 2016 Oct; 16(10):89. PubMed ID: 27523648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of the role of gut dysbiosis in type 1 diabetes.
    Abdellatif AM; Sarvetnick NE
    J Diabetes; 2019 Aug; 11(8):632-644. PubMed ID: 30864231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic exercise on gut microbiota and intestinal barrier in human with type 2 diabetes.
    Pasini E; Corsetti G; Assanelli D; Testa C; Romano C; Dioguardi FS; Aquilani R
    Minerva Med; 2019 Feb; 110(1):3-11. PubMed ID: 30667205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].
    Bischoff SC
    Internist (Berl); 2017 May; 58(5):441-448. PubMed ID: 28432400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study.
    Harbison JE; Roth-Schulze AJ; Giles LC; Tran CD; Ngui KM; Penno MA; Thomson RL; Wentworth JM; Colman PG; Craig ME; Morahan G; Papenfuss AT; Barry SC; Harrison LC; Couper JJ
    Pediatr Diabetes; 2019 Aug; 20(5):574-583. PubMed ID: 31081243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, diabetes, and the gut microbiome: an updated review.
    Singer-Englar T; Barlow G; Mathur R
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):3-15. PubMed ID: 30791839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of small intestinal bacterial overgrowth in obesity and its related diseases.
    Yao Q; Yu Z; Meng Q; Chen J; Liu Y; Song W; Ren X; Zhou J; Chen X
    Biochem Pharmacol; 2023 Jun; 212():115546. PubMed ID: 37044299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microbiome, diabetes and heart: a novel link?].
    Kappel BA; Lehrke M
    Herz; 2019 May; 44(3):223-230. PubMed ID: 30847506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and the Gut Microbiome.
    Lau WL; Tran T; Rhee CM; Kalantar-Zadeh K; Vaziri ND
    Semin Nephrol; 2021 Mar; 41(2):104-113. PubMed ID: 34140089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus.
    Sohail MU; Althani A; Anwar H; Rizzi R; Marei HE
    J Diabetes Res; 2017; 2017():9631435. PubMed ID: 29082264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.